LY2881835

LY2881835 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2881835, covering 2019-06-19 to 2019-06-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2881835 in Healthy People and People With Diabetes [Phase 1]